QUOTE AND NEWS
Benzinga  Aug 9  Comment 
JMP reiterated its Market Outperform rating and $16 price target on Akebia Therapeutics Inc (NASDAQ: AKBA). The company reported a 2Q16 net loss of $35.8 million, or ($0.95) per share vs. JMP's estimate of ($0.59) per share. It also announced...
Benzinga  Aug 9  Comment 
Twilio Inc (NYSE: TWLO) reported results for its first quarter as a public company for 2Q16, with the revenue and EPS meaningfully beating expectations. JMP’s Patrick Walravens maintained a Market Perform rating on the company. The company...
Benzinga  Aug 2  Comment 
JMP Securities reiterated its Market Outperform rating and $5 price target on Bovie Medical Corporation (NYSE: BVX) following 2Q16 results. The company posted revenues of $9.3 million in the quarter vs. JMP's $8.0 million estimate with...
SeekingAlpha  Jul 18  Comment 
Benzinga  Jun 22  Comment 
JMP Securities analysts Ronald Josey, Shweta Khajuria and Andrew Boone have an increasingly positive view on Amazon.com, Inc. (NASDAQ: AMZN)'s Amazon Web Services. The brokerage reiterated its Market Perform rating and $775 price target. Their...
newratings.com  Jun 16  Comment 
Summit Therapeutics plc ("Summit" or the "Company") SUMMIT THERAPEUTICS TO PRESENT AT JMP SECURITIES LIFE SCIENCES CONFERENCE Oxford, UK, 16 June 2016 - Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM), the drug discovery and ...
Benzinga  Jun 7  Comment 
The FDA has asked Sarepta Therapeutics Inc (NASDAQ: SRPT) to provide dystrophin data, as part of the ongoing evaluation of the eteplirsen NDA [New Drug Application]. JMP Securities’ Liisa A. Bayko reiterated a Market Underperform rating for the...





You may also be interested in articles related to JMP Group (JMP):
 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki